期刊文献+

表面增强的激光解析电离飞行时间质谱技术在肝细胞癌血清学诊断中的应用 被引量:3

Application of surface enhanced laser desorption ionization time-of-flight mass spectrometry technology in the diagnosis of hepatocellular carcinoma
下载PDF
导出
摘要 目的:检测HBV感染携带者与肝细胞癌(HCC)患者血清蛋白质的差异性表达,以发现HCC的肿瘤诊断标志物.方法:用表面增强的激光解析电离飞行时间质谱(SELDI-TOF-MS)技术检测27例HCC患者,27例HBV感染携带者,25例健康对照血清中的蛋白质谱,并用Biomarker Patterns System 5.0软件分析,建立诊断模型.结果:检测HCC患者与HBV感染携带者。正常对照与HCC患者,正常对照与HBV感染携带者的差异性蛋白分子,据此构建分类模型,得到的灵敏度和特异度分别为93%,85%; 96%,96%;84%,89%.其中相对分子质量为8141 Da的蛋白峰在HCC组明显高于HBV感染组(p<10-5);相对分子质量为3448 Da的蛋白峰在HCC及HBV感染携带组表达均较正常组显著增高(P<10-5),而在HCC-HBV组无明显差异(P>0.05),提示其可能为HBV感染的一种标志蛋白;相对分子质量为777) Da的蛋白峰在3组中均有差异性表达.结论:SELDI蛋白芯片技术检测血清蛋白质谱法诊断HCC具有较高的灵敏度和特异度,操作简单快捷,临床应用前景广阔,为HCC诊断提供了新的血清学方法. AIM: To explore tumor markers for the diagnosis of hepatocellular carcinoma (HCC) through detecting the serum protein spectrum differently expressed between hepatitis B virus (HBV) carriers and HCC patients. METHODS: We detected the serum protein spectrum in 27 HCC patients, 27 HBV carriers and 25 healthy controls using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technique, and the diagnosis model was established through analyzing the detected data by biomarker patterns software (BPS) 5.0. RESULTS: The protein peaks, which could discriminate HBV carriers from HCC patients and healthy individuals, as well as healthy individuals from HCC patients, were detected. A diagnosis model based on the detected data was established with the specificity of 93%, 96%, 84%, and sensitivity of 85%, 96%, 89%, respectively. In addition, the 8141-Da protein in HCC patients had a higher expression than that in HBV carriers (P 〈 10^-5); the expression of 3448-Da protein was higher both in HCC patients and HBV carriers than that in healthy controls (P 〈 10^-5), but it had no significant difference between HCC patients and HBV carriers (P 〉 0.05), indicating that 3448-Da protein might be a potential marker for HBV infection; 7771-Da protein was differently expressed between the three groups of patients. CONCLUSION: With a high specificity and sensitivity, the detection of serum protein spectrum can be performed easily and quickly by SELDI-TOF-MS technique, which provides a serological way for the diagnosis of HCC.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第25期2499-2503,共5页 World Chinese Journal of Digestology
基金 青岛市科技局资助项目 No.2004-11~~
关键词 肝细胞癌 蛋白质组学 肿瘤标志物 表面增强的激光解析电离飞行时间质谱 Hepatocellular carcinoma Proteomics Tumor marker Surface enhanced laser desorption ionization time-of-flight mass spectrometry
  • 相关文献

参考文献11

  • 1Robinson JC,Kerjan P,Mirande M.Macromolecular assemblage of aminoacyl-tRNA synthetases:quantitative analysis of protein-protein interactions and mechanism of complex assembly.J Mol Biol 2000; 304:983-994
  • 2Stoop AA,Jespers L,Lasters I,Eldering E,Pannekoek H.High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions:application to study structure-function of plasminogen activation inhibitor 1 (PAI-I).J Mol Biol 2000; 301:1135-1147
  • 3Vlahou A,Schellhammer PF,Mendrinos S,Patel K,Kondylis FI,Gong L,Nasim S,Wright Jr GL Jr.Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.Am J Pathol 2001; 158:1491-1502
  • 4Petricoin EF,Ardekani AM,Hitt BA,Levine PJ,Fusaro VA,Steinberg SM,Mills GB,Simone C,Fishman DA,Kohn EC,Liotta LA.Use of proteomic patterns in serum to identify ovarian cancer.Lancet 2002; 359:572-577
  • 5Adam BL,Qu Y,Davis JW,Ward MD,Clements MA,Cazares LH,Semmes OJ,Schellhammer PF,Yasui Y,Feng Z,Wright GL Jr.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.Cancer Res 2002; 62:3609-3614
  • 6Li J,Zhang Z,Rosenzweig J,Wang YY,Chan DW.Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.Clin Chem 2002; 48:1296-1304
  • 7曹基辉,张静,翟成凯,钱耕荪.乙肝病毒X基因与肝细胞肝癌[J].国外医学(病毒学分册),2003,10(1):28-31. 被引量:1
  • 8Carrette O,Demalte I,Scherl A,Yalkinoglu O,Corthals G,Burkhard P,Hochstrasser DF,Sanchez JC.A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.Proteomics 2003; 3:1486-1494
  • 9Hayman MW,Przyborski SA.Proteomic identification of biomarkers expressed by human pluripotent stem cells.Biochem Biophys Res Commun 2004; 316:918-923
  • 10MelleC,Kaufmann R,Hommann M,Bleul A,Driesch D,Ernst G,von Eggeling F.Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology.Int J Oncol 2004; 24:885-891

二级参考文献24

  • 1Wu CG, et al. FASEB J,2002;7:153-158
  • 2Chi Tarn, et al. The Journal of Biological Chemistry,1999;274(4):2327-2336
  • 3Alexio Capovilla, et al. Biochemical And Biophysical Research Communications, 1997; 232 : 255 ~260
  • 4Linbin JJia, et al. Int.J Cancer,1999;80:875-879
  • 5Bouchard MJ, et al. Science, 2001; 294 (5550):2376-2378
  • 6Ganem D. Virology Science, 2001; 294 (5550):2299-2300
  • 7Livezey K, et al. Mutat Res,2002;505(1-2):63
  • 8Koike K, et al. Oncology,2002;62(1):29-37
  • 9Caselmann WH. Adv Virus Res, 1996; 47: 253-302
  • 10Luber B, et al. Oncogene,1996;12:1597-1608

同被引文献27

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部